2 Stocks Near 52-Week Low Worth Selling (KERX, CLSN)

Los Angelas, CA -- (SBWIRE) -- 02/01/2013 -- Keryx Biopharmaceuticals (NASDAQ:KERX) is trading at unusually high volume Friday with 8.8 million shares changing hands. It is currently at two times its average daily volume and trading down 67 cents (-7.4%) at $8.41.

Keryx has a market cap of $610.7 million and is part of the health care sector and drugs industry. Shares are up 224% year to date as of the close of trading on Thursday.

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease.

Get A Free Report And Detailed Analysis On KERX Click Here

Celsion Corporation (NASDAQ:CLSN) reported a plunge of -81.17% after opening at the price of $1.59. Its closing price for the day was $1.51.

CLSN’s total trading volume for the day was 42.16 million shares, versus its average volume of 2.47 million shares. The Company’s current market capitalization stands at $52.87 million along with 35.01 million shares.

Celsion’s earnings per share is $-0.76, while its beta value stands at 1.19 times. If we look at the previous 5 day’s performance of the stock, it remained decreasing with the loss of -78.43% and, in its last one month’s trade it plunged -81.56%.

Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.

Get Free Trend Analysis on To Know More About CLSN Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com